Drug profile · INN
chlorzoxazone
CHLORZOXAZONE
chlorzoxazone (CHLORZOXAZONE) is a intermediate conductance calcium-activated potassium channel protein 4 opener. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — chlorzoxazone
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
chlorzoxazone (CHLORZOXAZONE) is a intermediate conductance calcium-activated potassium channel protein 4 opener. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Intermediate conductance calcium-activated potassium channel protein 4 opener
Primary target: Intermediate conductance calcium-activated potassium channel protein 4
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is chlorzoxazone?
chlorzoxazone (CHLORZOXAZONE) is a intermediate conductance calcium-activated potassium channel protein 4 opener. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for chlorzoxazone?
CHLORZOXAZONE is a marketed brand name for chlorzoxazone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlorzoxazone?
chlorzoxazone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.